Drug Policy and Practice SARAH ABRUZZINI; BIOMEDICAL; DR. ANDREA - PowerPoint PPT Presentation

Jan 21, 2024 •271 likes •335 views

Easier to Get Heroin Than Help: Shifting the Discourse on U.S. Drug Policy and Practice SARAH ABRUZZINI; BIOMEDICAL; DR. ANDREA HILL UNIVERSITY OF WASHINGTON TACOMA https://www.seekpng.com/ipng/u2q8e6y3w7i1r5t4_spilled-pill-bottle-png-tablet/

Easier to Get Heroin Than Help: Shifting the Discourse on U.S. Drug Policy and Practice SARAH ABRUZZINI; BIOMEDICAL; DR. ANDREA HILL UNIVERSITY OF WASHINGTON TACOMA https://www.seekpng.com/ipng/u2q8e6y3w7i1r5t4_spilled-pill-bottle-png-tablet/
Portugal's Radical Approach... • Acceptance of addiction as condition needing medical care • Decriminalization of drug use and possession of small quantities • Focus on treatment and harm reduction • Civil fines and penalties for deterrence https://www.statista.com/chart/20616/key-developments-since-portugal-decriminalized-drugs/
Problems in the current U.S. system • Punitive system --> Mass incarceration • Compulsory treatment --> Focus on abstinence • Mundipharma --> global spread https://www.brennancenter.org/our-work/analysis-opinion/history-mass-incarceration
Meeting the experts... Dr. . Paul La Lakosky, , Ph.D .D. with the Tacoma Needle Exchange Mark Cooke, Policy Advocate with the ACLU Dr. . David Sapienza, , MD with Bupe Path thways Tiarra Dearbone, Project Manager with LE LEAD
Success and expansion of groups like LEAD Harm reduction as effective approach Reasons for hope... Infrastructure in place for shift Public opinion on the cusp of change

Recommend

Drug Testing in Child Welfare: A Discussion of Practice and Policy Practice and Policy

Drug Testing in Child Welfare: A Discussion of Practice and Policy Practice and Policy Considerations Nancy K. Young, Ph.D. Presented at the: Missouri Department of Mental Health Missouri Department of Mental Health Spring Training

694 views • 22 slides

A 21 st Century Drug Policy: Implications for Research and Practice GRANTMAKERS IN HEALTH

A 21 st Century Drug Policy: Implications for Research and Practice GRANTMAKERS IN HEALTH MEETING Behavioral Health Equity: Advancing Systems Change Washington, D.C. November 20, 2015 Michael P. Botticelli Director Office of National Drug

680 views • 31 slides

Young people and drug policy Alison Ritter, Kari Lancaster & Francis Matthew-Simmons Drug

Young people and drug policy Alison Ritter, Kari Lancaster & Francis Matthew-Simmons Drug Policy Modelling Program National Drug and Alcohol Research Centre, UNSW Research funded by: ANCD and DPMP (Colonial Foundation Trust) Policy and

689 views • 19 slides

Why We Make War on Some Drugs but Not on Others A Short History of Drug Use and Drug Policy David

Why We Make War on Some Drugs but Not on Others A Short History of Drug Use and Drug Policy David T. Courtwright dcourtwr@unf.edu LSE October 23, 2012 I have seen with my own eyes the terrible scourge drink can be. It has ruined people

628 views • 37 slides

Agenda Why Drug Importation? Legislative Framework for Drug Importation

11/13/2019 Drug Importation Stakeholder Update Senate Bill 19-005 Presented by: Kelly Swartzendruber , PharmD, Drug Importation, Health Care Policy & Finance 1 Agenda Why Drug Importation? Legislative Framework for Drug

522 views • 7 slides

Tackling the Opioid Epidemic: From Policy to Practice Robert Valuck, PhD, RPh, FNAP Departments

Tackling the Opioid Epidemic: From Policy to Practice Robert Valuck, PhD, RPh, FNAP Departments of Clinical Pharmacy, Epidemiology, and Family Medicine Director, Colorado Consortium for Prescription Drug Abuse Prevention October 26, 2018

1.01k views • 56 slides

UNDERSTANDING DRUG-RELATED STIGMA AND DISCRIMINATION Tools for Better Practice and Social

UNDERSTANDING DRUG-RELATED STIGMA AND DISCRIMINATION Tools for Better Practice and Social Change Harm Reduction Coalition 2010 Introductions Name Organization How do you interact with drug users? Goals Identify and explore

461 views • 23 slides

Drug Efficacy and Response Minutes of the TEG on Drug Efficacy and Response Malaria Policy

Drug Efficacy and Response Minutes of the TEG on Drug Efficacy and Response Malaria Policy Advisory Committee, Geneva, Switzerland, 16 March 2016 Outline Update on artemisinin resistance Monitoring efficacy and effectiveness of

765 views • 30 slides

Putting drug development into Putting drug development into practice for Pancreatic Cancer:

Putting drug development into Putting drug development into practice for Pancreatic Cancer: Malcolm J . Moore MD Head, Division of Medical Oncology and Hematology My Mentors My Mentors Pancreatic Cancer Ductal Adenocarcinom a

681 views • 17 slides

Policy in Practice The debt landscape in Deven Ghelani response to a changing policy

Policy in Practice The debt landscape in Deven Ghelani response to a changing policy environment Agenda About Policy in Practice The impact of recent policy changes on low income households Initiatives to help support vulnerable

319 views • 19 slides

Drug Policies Beyond the War on Drugs Dr Joanne Csete Dr John Collins Professor Lawrence

Hosted by LSE Works: LSE IDEAS Drug Policies Beyond the War on Drugs Dr Joanne Csete Dr John Collins Professor Lawrence Commissioner, Lancet Executive Director, International Phillips Commission on Drug Policy Drug Policy Project, LSE

756 views • 32 slides

Scottish Drug Forum June 19, 2018 Changing Perceptions and Practice - The Experience in British

Scottish Drug Forum June 19, 2018 Changing Perceptions and Practice - The Experience in British Columbia Jane Buxton MBBS, MHSc, FRCPC Harm reduction lead BC CDC Overview Background OD crisis Illicit drug deaths and the emergence of

849 views • 39 slides

Introduction to U.S. Drug Shortages CAPT Valerie Jensen, R.Ph. Associate Director Drug Shortage

As presented at the NCCS Cancer Policy Roundtable March 22-23, 2012 Introduction to U.S. Drug Shortages CAPT Valerie Jensen, R.Ph. Associate Director Drug Shortage Program Center for Drug Evaluation & Research U.S. Food & Drug

464 views • 10 slides

The demand for UNGASS 2016 came from specific Latin American countries, Colombia, Guatemala and

2015 Symposium on International Drug Control Policy Zhejiang Police College and East China University of Political Science and Law (October 16-20, Hangzhou) (unedited draft) Improving Global Drug Policy: The importance of UNGASS - the

541 views • 14 slides

Outcomes: Drug Harms, Policy Harms, Poverty and Inequality. Dr Aileen OGorman Senior Lecturer

Outcomes: Drug Harms, Policy Harms, Poverty and Inequality. Dr Aileen OGorman Senior Lecturer Contemporary Drug and Alcohol Studies University of the West of Scotland Main themes of the Research Report 1) Poverty, inequality and policy

834 views • 51 slides

Marijuana Facts The Rest of the Story Iowa Office of Drug Control Policy February 2015 1 An

Marijuana Facts The Rest of the Story Iowa Office of Drug Control Policy February 2015 1 An Important Distinction The Iowa Office of Drug Control Policy (ODCP) supports the development of safe, tested and effective research-based medicines,

532 views • 36 slides

Prescription Drug Monitoring Programs: A Policy with Limited Impact on the Opioid

Prescription Drug Monitoring Programs: A Policy with Limited Impact on the Opioid Painkiller Epidemic Courtney R. Yarbrough Ph.D. Candidate University of Georgia Department of Public Administration and Policy Supported by a

619 views • 38 slides

Drugs, internet, society Dr Monica Barratt 6th Annual ACT Alcohol, Tobacco and Other Drug Sector

Drugs, internet, society Dr Monica Barratt 6th Annual ACT Alcohol, Tobacco and Other Drug Sector Conference New and Emerging Technologies in ATOD Research, Policy, Practice and Participation Friday 21 June 2013 National Portrait Gallery of

697 views • 23 slides

Prescription Drug Monitoring Programs: A Policy with Limited Impact on the Opioid Painkiller

432 views • 39 slides

NGS in clinical Italian practice: impact of minor quasispecies on antiretroviral drug resistance

NGS in clinical Italian practice: impact of minor quasispecies on antiretroviral drug resistance and viral tropism AREVIR-GenaFor-Meeting Dr. Daniele Armenia Bonn 3th May 2012 Why use NGS in management of HIV-1 infection? Treatment begins

348 views • 33 slides

Cullman County SAFETY Policies & Procedures handbook Vehicle Fleet Safety Policy Drug and

Cullman County SAFETY Policies & Procedures handbook Vehicle Fleet Safety Policy Drug and Alcohol Abuse Policies & Procedures Seat Belt Policy Return to Work/Modified Duty Policy Usage of Wireless Communication Devices while

1.01k views • 69 slides

Taking Valium Before Presentation A common practice with dependency is coupling the drug with the

Taking Valium Before Presentation A common practice with dependency is coupling the drug with the use of alcoholic beverage. With only 1 is taken every 12 hours. Now also available as an App. John Renger was also at the bar. It is a must-have - a

200 views • 4 slides

Prescription Drug Rebates Impact on Policy in Colorado NAHDO 35 th Annual Conference August 25,

Prescription Drug Rebates Impact on Policy in Colorado NAHDO 35 th Annual Conference August 25, 2020 Vinita Bahl, DMD, MPP Agenda Introduction Prescription drug rebates how do they work? Colorado initiative to collect rebate

177 views • 14 slides

Allergy and Immunology Pearls for Clinical Practice No discussion of non FDA approved

Nothing to declare Allergy and Immunology Pearls for Clinical Practice No discussion of non FDA approved medication use Katherine Gundling, MD FACP Professor, Section Chief Allergy and Immunology UCSF Adverse Drug Reactions Adverse Drug

439 views • 11 slides